Key Considerations for Foreign Clinical Trials When Looking Abroad for Product Development
By EsqSocial Corporation 02/04/25
With the continuing cuts to US Food and Drug Administration (FDA) staffing, the pharmaceutical and biotechnology industries are communicating increasing concern about potential product development impacts. While these cuts and their subsequent effects may be leading some companies to consider developing drugs abroad, such ex-US development can come with risks, necessitating upfront planning and compliance controls....
By: Morgan Lewis